| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015836115 |
| P356 | DOI | 10.1007/S11899-014-0223-4 |
| P698 | PubMed publication ID | 25218362 |
| P50 | author | Tait D Shanafelt | Q89771809 |
| P2093 | author name string | Sameer A Parikh | |
| P2860 | cites work | CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? | Q53322008 |
| Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. | Q53343426 | ||
| Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome | Q58000923 | ||
| A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome | Q58000942 | ||
| Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome | Q58001002 | ||
| CHRONIC LYMPHOID LEUKEMIA SECONDARILY ASSOCIATED WITH A MALIGNANT RETICULOPATHY: RICHTER'S SYNDROME | Q76928282 | ||
| Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy | Q77052608 | ||
| Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia | Q83432283 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy | Q28256358 | ||
| A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia | Q28943318 | ||
| A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia | Q28943555 | ||
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness | Q29013141 | ||
| Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial | Q33291990 | ||
| Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases | Q33682722 | ||
| Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients | Q33903379 | ||
| Genetics of follicular lymphoma transformation | Q33910446 | ||
| Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia | Q34009015 | ||
| SF3B1 and other novel cancer genes in chronic lymphocytic leukemia | Q34093678 | ||
| Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation | Q34528000 | ||
| Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712 | Q34879367 | ||
| Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. | Q34973576 | ||
| Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer | Q35125971 | ||
| Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma | Q35569501 | ||
| Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies | Q36083000 | ||
| Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia | Q36141922 | ||
| Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome | Q37246532 | ||
| How we treat Richter syndrome | Q37636962 | ||
| Richter syndrome | Q38135347 | ||
| Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia. | Q41351462 | ||
| The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). | Q42256366 | ||
| Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. | Q44629915 | ||
| Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome | Q46585922 | ||
| Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia | Q46970944 | ||
| Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma | Q47739621 | ||
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. | Q51025698 | ||
| The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. | Q51609722 | ||
| NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. | Q53259951 | ||
| P433 | issue | 3 | |
| P921 | main subject | lymphocyte | Q715347 |
| P304 | page(s) | 294-299 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Current hematologic malignancy reports | Q26842233 |
| P1476 | title | Risk factors for Richter syndrome in chronic lymphocytic leukemia | |
| P478 | volume | 9 |
| Q50074012 | Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies |
| Q52662919 | Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature. |
| Q54221806 | EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies. |
| Q40291554 | Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma |
| Q93035801 | First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia |
| Q91013331 | Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group. |
| Q48168654 | Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome. |
| Q99557890 | Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia |
| Q37632830 | Richter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and Molecular Diagnostics |
| Q64949407 | Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia. |
| Q64070485 | Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study |
| Q59808738 | The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies |
| Q99563209 | [Clinical value of PET/CT in the diagnosis of Richter syndrome] |
Search more.